Clinical Trial Update: Dose-Finding Safety and Efficacy Trial of Org 50081 (Esmirtazapine) in the Treatment of Vasomotor Symptoms (177001/P06472/MK-8265-013) [Phase 3]

View source ↗

Summary

Phase 3 dose-finding trial assessing safety and efficacy of Org 50081 (Esmirtazapine) for vasomotor symptoms in postmenopausal menopause; study completed with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause
• Postmenopausal Symptoms
• Vasomotor Symptoms

Drugs mentioned

• Org 50081

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Postmenopausal Symptoms, Menopause | Phase 3 | Status: COMPLETED | Results posted: 2014-07-30